monoclonal antibodies

Biotech

Ikena, after tough year of layoffs, merges with Inmagene

After a year that saw Ikena trim its workforce and pipeline, the oncology biotech thinks it’s found a path forward via a merger into Inmagene.

James Waldron Dec 23, 2024 10:00am

Photo of an ax atop a pile of three logs

Pyxis whittles pipeline down to one clinical asset

Dec 20, 2024 6:15am

Hand reaching for juice on grocery store shelf

Genmab buys 2nd antibody from Scancell in deal worth up to $630M

Dec 4, 2024 11:55am

Sketch of lungs

Roivant’s midstage asset fails to show benefit in lung disease

Dec 3, 2024 10:32am

Graphic showing arrows missing the bullseye on a target

Alector lays off 17% of staff after ph. 2 Alzheimer's drug fail

Nov 26, 2024 4:50am

Graphic image of a pen signing a signature while two strangelooking business people cheer

Lilly taps Oblique for new angle on high-value antibody target

Aug 22, 2024 9:13am